Harmony Biosciences officer plans $1.2M stock sale
Officer Kumar Budur has filed to sell up to 28,454 HRMY shares under Rule 144, with prior 10b5-1 sales also reported.
Rhea-AI Filing Summary
Harmony Biosciences Holdings, Inc. (HRMY) received a Rule 144 notice from officer Kumar Budur covering the proposed sale of up to 28,454 shares of common stock through Morgan Stanley Smith Barney LLC. The shares have an aggregate market value of $1,202,181.50 and are listed on NASDAQ, with 58,236,393 shares outstanding as of September 8, 2026.
The shares to be sold were acquired from vested restricted stock units between January 24, 2025 and January 25, 2026, from the employee stock purchase plan on November 30, 2022 and May 31, 2023, and from the exercise of stock options on September 8, 2026. In the prior three months, Budur reported a 10b5-1 sale of 5,500 shares for proceeds of $230,911.45.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold under Rule 144: 28,454 shares
Aggregate market value of shares to be sold: $1,202,181.50
Shares outstanding: 58,236,393 shares
+5 more
8 metrics
Shares to be sold under Rule 144
28,454 shares
Common stock proposed for sale by officer Kumar Budur
Aggregate market value of shares to be sold
$1,202,181.50
Estimated value of 28,454 Harmony Biosciences shares covered by the notice
Shares outstanding
58,236,393 shares
Harmony Biosciences common stock outstanding as of September 8, 2026
RSU shares to be sold
4,495 shares
Acquired from vesting of restricted stock units on January 24, 2025
ESPP shares to be sold
1,005 shares
Acquired under the employee stock purchase plan on November 30, 2022
Option exercise shares to be sold
22,954 shares
Acquired from exercise of stock options on September 8, 2026
Recent 10b5-1 sale shares
5,500 shares
Sold on September 4, 2026 for $230,911.45
Proceeds from recent 10b5-1 sale
$230,911.45
Total consideration for 5,500 shares sold on September 4, 2026
Key Terms
Rule 144, Restricted Stock Units, Employee Stock Purchase Plan, Exercise of Stock Options, +1 more
5 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Units financial
"Common | 01/24/2025 | Restricted Stock Units | Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Purchase Plan financial
"Common | 11/30/2022 | Employee Stock Purchase Plan | Issuer"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Exercise of Stock Options financial
"Common | 09/08/2026 | Exercise of Stock Options | Issuer"
10b5-1 regulatory
"10b5-1 Sales for KUMAR BUDUR"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
FAQ
What are the recent 10b5-1 sales reported for HRMY by Kumar Budur?
The filing reports a 10b5-1 sale of Harmony Biosciences common stock on September 4, 2026, covering 5,500 shares for total proceeds of $230,911.45. This transaction occurred within the three months prior to the new Rule 144 notice.
Which broker is handling the planned HRMY Rule 144 sale for Kumar Budur?
The proposed sale of Harmony Biosciences shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as identified in the Rule 144 filing.
What is the role of Kumar Budur at Harmony Biosciences (HRMY) as stated in the notice?
The Rule 144 notice identifies Kumar Budur as an officer of Harmony Biosciences Holdings, Inc. The filing is made for the account of this officer in connection with the planned sale of company common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
